Free tool
Heavily traded stocks
We cover 11 companies whose typical session turns over more than $10.00M. The median market value in the group is $263.12B. Across the group, the median move over the past trading day is −1.53%. Price change over the past year runs from +5.1% to +86.8% across the middle 80 percent of the group, with a median of +46.0%.
Other lists in this group
Table
11 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.